BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35945590)

  • 21. The CT and MRI Features of Primary Intrahepatic Lymphoepithelioma-Like Cholangiocarcinoma.
    Yang Q; Cai Q; Wen H; Mao Y; Ban X; Rong D; Zhang R
    AJR Am J Roentgenol; 2021 Feb; 216(2):393-402. PubMed ID: 33325732
    [No Abstract]   [Full Text] [Related]  

  • 22. [Carcinoma with predominant lymphoid stroma in hepatobiliary system--report of 2 cases].
    Min HS; Shin E; Jang JJ
    Korean J Hepatol; 2007 Jun; 13(2):222-7. PubMed ID: 17585195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epstein-Barr virus associated lymphoepithelioma-like cholangiocarcinoma: a clinicopathological analysis of three cases].
    Du MZ; Guo LC; Huang S; Guo X; Zhu BY
    Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):841-843. PubMed ID: 37527991
    [No Abstract]   [Full Text] [Related]  

  • 24. Surgical treatment of Epstein-Barr virus-associated lymphoepithelioma-like carcinoma occurring in both the posterior mediastinum and liver: Case report.
    Qian XH; Zhou DK; Wang WL
    Medicine (Baltimore); 2020 Dec; 99(52):e23610. PubMed ID: 33350736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hidden Carcinoma: Pitfalls in the Diagnosis of Lymphoepithelioma-Like Cholangiocarcinoma.
    Mostyka M; Birch MM; Samstein B; Pittman ME
    Int J Surg Pathol; 2020 Dec; 28(8):872-878. PubMed ID: 32429781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma.
    Chiang NJ; Hou YC; Tan KT; Tsai HW; Lin YJ; Yeh YC; Chen LT; Hou YF; Chen MH; Shan YS
    Hepatol Int; 2022 Oct; 16(5):1137-1149. PubMed ID: 35780451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conversion therapy for advanced intrahepatic cholangiocarcinoma with lenvatinib and pembrolizumab combined with gemcitabine plus cisplatin: A case report and literature review.
    Zhang W; Luo C; Zhang ZY; Zhang BX; Chen XP
    Front Immunol; 2022; 13():1079342. PubMed ID: 36700218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PD-1 blockade and radiotherapy combination for advanced Epstein-Barr virus-associated intrahepatic cholangiocarcinoma: a case report and literature review.
    Liao CX; Deng CS; Liang X; Yang JC; Chen ZZ; Lin XY; Lin CF; Chen S; Wu SS
    Front Immunol; 2023; 14():1239168. PubMed ID: 37753076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphoepithelioma-like neoplasm of the biliary tract with 'probable low malignant potential'.
    Khandakar B; Liu JR; Thung S; Li Y; Rhee H; Kagen AC; Sun-Wing Tong T; Nyun Park Y; Theise N; Oi-Lin Ng I
    Histopathology; 2022 Mar; 80(4):720-728. PubMed ID: 34608670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant expression of alpha-fetoprotein in intrahepatic cholangiocarcinoma: an exceptional occurrence.
    Vij K; Wang HL
    Int J Surg Pathol; 2008 Apr; 16(2):194-8. PubMed ID: 18417680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphoepithelioma-like cholangiocarcinoma not associated with EBV.
    Adachi S; Morimoto O; Kobayashi T
    Pathol Int; 2008 Jan; 58(1):69-74. PubMed ID: 18067645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined hepatocellular carcinoma-cholangiocarcinoma in a patient with Fontan-associated liver disease.
    Jou J; Li J; Kaldas FM
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36343983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrahepatic mass-forming cholangiocarcinoma growing in a giant hepatic hemangioma: A case report.
    Zhou M; Ling W; Luo Y
    Medicine (Baltimore); 2019 Jul; 98(27):e16410. PubMed ID: 31277198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus-associated intrahepatic cholangiocarcinoma bearing an intense lymphoplasmacytic infiltration.
    Xiao P; Shi H; Zhang H; Meng F; Peng J; Ke Z; Wang K; Liu Y; Han A
    J Clin Pathol; 2012 Jun; 65(6):570-3. PubMed ID: 22267965
    [No Abstract]   [Full Text] [Related]  

  • 36. First Reported Case of Primary Intrahepatic Cholangiocarcinoma with Pure Squamous Cell Histology: A Case Report.
    Lubana SS; Singh N; Seligman B; Tuli SS; Heimann DM
    Am J Case Rep; 2015 Jul; 16():438-44. PubMed ID: 26158884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An EBV+ lymphoepithelioma-like cholangiocarcinoma in a young woman with chronic hepatitis B.
    Gearty SV; Al Jurdi A; Pittman ME; Gupta R
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31289161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver.
    Morita D; Kagata Y; Ogata S; Tsuda H; Hatsuse K; Mochizuki H; Matsubara O
    Pathol Int; 2006 Apr; 56(4):222-6. PubMed ID: 16634969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoprotein.
    Zhou YM; Yang JM; Li B; Yin ZF; Xu F; Wang B; Liu P; Li ZM
    World J Gastroenterol; 2008 Apr; 14(14):2251-4. PubMed ID: 18407604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
    Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
    J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.